Strides Pharma shares sold by 2 entities for Rs 81 crore
Bangalore: Two entities including Bajaj Finance have sold shares of Strides Pharma Science for Rs 81 crore through open market transactions. According to the block deal data available with the BSE, Bajaj Finance offloaded more than 8 lakh shares of Strides Pharma in two tranches and Shasun Leasing & Finance (promoter group entity of Strides Pharma) disposed of 3.35 lakh shares of the company.
Around 11.40 lakh shares were sold, which represents a 1.24 per cent stake in the company. The shares were sold at an average price of Rs 713 per piece, taking the combined transaction value to Rs 81.30 crore. Meanwhile, Amansa Holding acquired these shares at the same price.
Read also: Strides Pharma Science Singapore arm gets USFDA okay for fibromyalgia drug Pregabalin
Recently, Promoters of Mankind Pharma has divested a 1.62 per cent stake in the company for Rs 1,367 crore through open market transactions.
Read also: Mankind Pharma promoters divest 1.6 percent stake worth Rs 1367 crore
Strides, a global pharmaceutical company headquartered in Bengaluru, India, is listed on the BSE Limited and National Stock Exchange of India Limited (STAR). The Company mainly operates in the regulated markets and has an “in Africa for Africa” strategy and an institutional business to service donor‐ funded markets. The Company’s global manufacturing sites are located in India (Chennai, Puducherry, and two locations in Bengaluru), Italy (Milan), Kenya (Nairobi) and the United States (New York).
